Guy Van Den Mooter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guy Van Den Mooter has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Augustijns
Drug Delivery and Disposition, KU Leuven, Herestraat 49 box 921, 3000 Leuven, Belgium
5 shared publications R. Kinget
K. U. Leuven
5 shared publications- Lieve Naesens
Rega Institute for Medical Research, KU Leuven, Herestraat 49, 3001 Leuven, Belgium
2 shared publications N. Blaton
K. U. Leuven
2 shared publicationsP. Augustijns
Katholieke Universiteit Leuven
2 shared publicationsB. Maris
Laboratorium voor Farmacotechnologie en Biofarmacie, K. U. Leuven, Belgium
1 shared publication
Latest Publications
- 1 May 2002
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 68 (2) , 591-601
Thermal Properties of Hot-Stage Extrudates of Itraconazole and Eudragit E100. Phase separation and polymorphism
- 1 May 2002
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 68 (2) , 591-601
Thermal Properties of Hot-Stage Extrudates of Itraconazole and Eudragit E100. Phase separation and polymorphism
- 1 February 2002
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 54 (2) , 197-203
Influence of the composition of in-vitro azo-reducing systems on the degradation kinetics of the model compound amaranth
The purpose of this study was to investigate the influence of the composition of in-vitro azoreducing systems on the degradation kinetics of the model compound amaranth. The degradation kinetics of amaranth were determined under anaerobic conditions both in rat caecal content (ex-vivo) and in a variety of in-vitro degradation media derived from rat caecal content. It was observed that the reducing activity was highly dependent on the preparation method and composition of the degradation medium. In pure rat caecal content, the degradation of amaranth was apparent first order (k = 0.044+0.002 min−1), while dilution of the rat caecal content resulted in an apparentzero-orderdegradation. Both apparentzero- and first-order degradations were also observed in media made up of diluted rat caecal content to which cofactors such as NADP, D-glucose-6-phosphate, glucose-6-phosphate dehydrogenase and Bz were added. This study demonstrates that in-vitro azo-reducing kinetics are dependent on the composition and mode of preparation of the in-vitro media used. This has to be taken into account when evaluating the degradability of azo-aromatic drug delivery systems in-vitro.
- 1 February 2002
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 54 (2) , 197-203
Influence of the composition of in-vitro azo-reducing systems on the degradation kinetics of the model compound amaranth
The purpose of this study was to investigate the influence of the composition of in-vitro azoreducing systems on the degradation kinetics of the model compound amaranth. The degradation kinetics of amaranth were determined under anaerobic conditions both in rat caecal content (ex-vivo) and in a variety of in-vitro degradation media derived from rat caecal content. It was observed that the reducing activity was highly dependent on the preparation method and composition of the degradation medium. In pure rat caecal content, the degradation of amaranth was apparent first order (k = 0.044+0.002 min−1), while dilution of the rat caecal content resulted in an apparentzero-orderdegradation. Both apparentzero- and first-order degradations were also observed in media made up of diluted rat caecal content to which cofactors such as NADP, D-glucose-6-phosphate, glucose-6-phosphate dehydrogenase and Bz were added. This study demonstrates that in-vitro azo-reducing kinetics are dependent on the composition and mode of preparation of the in-vitro media used. This has to be taken into account when evaluating the degradability of azo-aromatic drug delivery systems in-vitro.
- 1 August 2001
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 53 (8) , 1109-1116
Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30)
The purpose of this study was to elucidate the physical structure of solid dispersions of the antiviral agent UC-781 (N-[4-chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furancarbo-thioamide) with polyvinylpyrrolidone (PVP K30). Solid dispersions were prepared by co-evaporating UC-781 with PVP K30 from dichloromethane. The physicochemical properties of the dispersions were evaluated in comparison with the physical mixtures by differential scanning calorimetry (DSC), X-ray powder diffraction, and FT-IR spectroscopy. We investigated the single crystal structure of pure UC-781. The data from single crystal analysis showed that UC-781 crystallized with orthorhombic symmetry in the space group Pcab. Its cell parameters were found to be; a = 8.1556(7) Å, b = 17.658(2) Å and c = 23.609(2) Å; the unit cell was made up of eight molecules of UC-781. The molecules formed intermolecular hydrogen bonds between NH and thio groups, and were packed in a herringbone-like structure. The data from X-ray powder diffraction showed that crystalline UC-781 was changed into the amorphous state by co-evaporating it with PVP K30. From differential scanning calorimetry analysis, UC-781 peaks were observed in the DSC curves of all physical mixtures, while no peaks corresponding to the drug could be observed in the solid dispersions with the same drug composition up to the concentration of 50% w/w. The data from FT-IR spectroscopy showed the distortions and disappearance of some bands from the drug, while other bands were too broad or significantly less intense compared with the physical mixtures of the crystalline drug in PVP K30. Furthermore, the results from IR spectroscopy demonstrated that UC-781 interacted with PVP K30 in solid dispersions through intermolecular H-bonding.
- 1 August 2001
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 53 (8) , 1109-1116
Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30)
The purpose of this study was to elucidate the physical structure of solid dispersions of the antiviral agent UC-781 (N-[4-chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furancarbo-thioamide) with polyvinylpyrrolidone (PVP K30). Solid dispersions were prepared by co-evaporating UC-781 with PVP K30 from dichloromethane. The physicochemical properties of the dispersions were evaluated in comparison with the physical mixtures by differential scanning calorimetry (DSC), X-ray powder diffraction, and FT-IR spectroscopy. We investigated the single crystal structure of pure UC-781. The data from single crystal analysis showed that UC-781 crystallized with orthorhombic symmetry in the space group Pcab. Its cell parameters were found to be; a = 8.1556(7) Å, b = 17.658(2) Å and c = 23.609(2) Å; the unit cell was made up of eight molecules of UC-781. The molecules formed intermolecular hydrogen bonds between NH and thio groups, and were packed in a herringbone-like structure. The data from X-ray powder diffraction showed that crystalline UC-781 was changed into the amorphous state by co-evaporating it with PVP K30. From differential scanning calorimetry analysis, UC-781 peaks were observed in the DSC curves of all physical mixtures, while no peaks corresponding to the drug could be observed in the solid dispersions with the same drug composition up to the concentration of 50% w/w. The data from FT-IR spectroscopy showed the distortions and disappearance of some bands from the drug, while other bands were too broad or significantly less intense compared with the physical mixtures of the crystalline drug in PVP K30. Furthermore, the results from IR spectroscopy demonstrated that UC-781 interacted with PVP K30 in solid dispersions through intermolecular H-bonding.
- 1 August 2001
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 90 (8) , 996-1003
Characterization of amorphous ketoconazole using modulated temperature differential scanning calorimetry
- 1 August 2001
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 90 (8) , 996-1003
Characterization of amorphous ketoconazole using modulated temperature differential scanning calorimetry
- 3 January 2001
- Published by Elsevier in Thermochimica Acta
- Vol. 366 (1) , 61-69
Thermal characterization of the antiviral drug UC-781 and stability of its glass
- 3 January 2001
- Published by Elsevier in Thermochimica Acta
- Vol. 366 (1) , 61-69
Thermal characterization of the antiviral drug UC-781 and stability of its glass
- 1 January 2001
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (3) , 261-269
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25
- 1 January 2001
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (3) , 261-269
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25
- 1 August 1999
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 57 (2) , 493-507
Glass Forming Properties of Benzodiazepines and Co-evaporate Systems with Poly(hydroxyethyl Methacrylate)
- 1 August 1999
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 57 (2) , 493-507
Glass Forming Properties of Benzodiazepines and Co-evaporate Systems with Poly(hydroxyethyl Methacrylate)